CSat Investment Advisory’s Dentsply Sirona XRAY Stock Holding History

CSat Investment Advisory’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$61K	Sell	951 -4	-0.4%	-$232	0.05%	151
2020 Q4	$50K	Sell	955 -1,679	-64%	-$82.8K	0.05%	153
2020 Q3	$115K	Buy	2,634 +136	+5%	+$6.01K	0.01%	409
2020 Q2	$110K	Buy	2,498 +1,319	+112%	+$55.8K	0.01%	438
2020 Q1	$46K	Buy	1,179 +332	+39%	+$16.9K	0.01%	550
2019 Q4	$47K	Buy	847 +104	+14%	+$5.8K	0.01%	635
2019 Q3	$40K	Buy	743 +129	+21%	+$6.93K	0.01%	616
2019 Q2	$35K	Buy	614 +63	+11%	+$3.38K	0.01%	631
2019 Q1	$27K	Sell	551 -262	-32%	-$11.5K	0.01%	252
2018 Q4	$30K	Buy	813 +189	+30%	+$6.88K	0.02%	201
2018 Q3	$24K	Buy	624 +213	+52%	+$8.87K	0.01%	196
2018 Q2	$18K	Buy	+411	New	+$19.3K	0.01%	224

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CSat Investment Advisory's XRAY Position: Q1 2021 in Review

CSat Investment Advisory reduced its Dentsply Sirona (XRAY) stake by 0.42% in Q1 2021, selling an estimated $232 and leaving 951 shares worth $61K. The position accounts for 0.05% of the portfolio, ranked #151.

CSat Investment Advisory first reported a position in XRAY in Q2 2018 and has held it in 12 quarters since. The position peaked at $115K in Q3 2020. 541 funds tracked by Wall St. Rank hold XRAY as of Q1 2021.

CSat Investment Advisory held 951 shares of Dentsply Sirona worth $61K as of Q1 2021.
CSat Investment Advisory sold 4 Dentsply Sirona shares in Q1 2021, an estimated $232.
Dentsply Sirona made up 0.05% of CSat Investment Advisory's portfolio in Q1 2021, its #151 holding.
CSat Investment Advisory first reported a position in Dentsply Sirona in Q2 2018 and has held it in 12 quarters since.
CSat Investment Advisory's Dentsply Sirona position peaked at $115K in Q3 2020.
541 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.